This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Jun;61(6):1265-6.

doi: 10.1016/j.eururo.2012.03.028.

Words of wisdom: Re: Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial

Bertrand Tombal¹, Frederic Lecouvet

Affiliations

Affiliation

¹ Service d'Urologie, Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Av Hippocrate 10, B-1200 Brussels, Belgium. Bertrand.tombal@uclouvain.be

PMID: 22542091
DOI: 10.1016/j.eururo.2012.03.028

Comment

Words of wisdom: Re: Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial

Bertrand Tombal et al. Eur Urol. 2012 Jun.

. 2012 Jun;61(6):1265-6.

doi: 10.1016/j.eururo.2012.03.028.

Authors

Bertrand Tombal¹, Frederic Lecouvet

Affiliation

¹ Service d'Urologie, Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Av Hippocrate 10, B-1200 Brussels, Belgium. Bertrand.tombal@uclouvain.be

PMID: 22542091
DOI: 10.1016/j.eururo.2012.03.028

No abstract available

PubMed Disclaimer

Comment on

Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.
Fleshner NE, Lucia MS, Egerdie B, Aaron L, Eure G, Nandy I, Black L, Rittmaster RS. Fleshner NE, et al. Lancet. 2012 Mar 24;379(9821):1103-11. doi: 10.1016/S0140-6736(11)61619-X. Epub 2012 Jan 24. Lancet. 2012. PMID: 22277570 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science